Inventor · disambiguated record
Steve Swann
Also filed as: SWANN JR STEVE · SWANN STEVE · SWANN STEVE L
6 granted patents·2 pending applications·7 citations·filing 2008–2025
72Inventor score
Top patents by PatentIndex Score
8 records- 0191US11236099B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 1, 2022·4 cites·22 claims
- 0277US8445686B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsMACK HELMUT·Filed 2008·Granted May 21, 2013·3 cites·21 claims
- 0366US12378256B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 0460US12162864B2Condensed-cyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 0552US2025289792A13-amino-4h-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of mrgx2SOLENT THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 0650US12247015B23-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2SOLENT THERAPEUTICS LLC·Filed 2020·Granted Mar 11, 2025·0 cites·22 claims
- 0750US2023158010A1Luminally-acting n-(piperidin-4-yl)benzamide derivativesGIBSON TONY S·Filed 2021·Application pending·0 cites
- 0833US9994547B2Heteroarylamide inhibitors of TBK1TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 12, 2018·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Steve Swann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →